Spinal Muscular Atrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be able to walk at least 10 meters (about 33 feet) on your own, without help from another person or a mobility aid.
- You must have a confirmed diagnosis of one of the conditions being studied, based on appropriate testing such as genetic tests or clinical assessment.
- If you have Myotonic Dystrophy Type 1 (DM1) or Charcot-Marie-Tooth disease (CMT), you must show signs of nerve or muscle problems during a physical examination.
- If you have Myasthenia Gravis, a specific antibody must have been detected in your blood, and your condition must fall within a certain range of severity (moderate to more severe symptoms, known as MGFA class II to IV — confirm with trial site).
- If you are joining due to severe obesity, your Body Mass Index (BMI) must be 35 or higher at the time of your first visit.
- You must be willing and able to sign a consent form and take part in all parts of the study.
Who may not be able to join:
- You may not be eligible if you are unable to walk on your own.
- You may not be eligible if you have severe cognitive (thinking or understanding) difficulties that would prevent you from following the study exercises.
- You may not be eligible if you have had surgery or a significant injury affecting your arms or legs within the last 6 months.
- You may not be eligible if you have had another ongoing or recent neurological, hormonal, infectious, allergic, or inflammatory condition in the 3 weeks before joining the trial.
- You may not be eligible if you are currently taking part in another clinical trial that involves a treatment or intervention.
- You may not be eligible if you are pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Laurent Servais, MD, Centre Hospitalier Universitaire de Liege
Phone: +3243218095
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
95th Centile of Stride Velocity (SV95C)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.